Chemotherapy helps many women survive breast cancer, but new research suggests the treatment may also accelerate biological aging and raise the risk of earlier death from other causes. Patients receiving the most intensive chemotherapy regimens could lose more than nine years of healthy life due to this accelerated aging, according to population-based simulation modeling published … Read more
When I was diagnosed with breast cancer, my background as a clinician and researcher led me to look for credible, evidence-based information, said Heather Kopecky, PhD, MBA, PCC, Member of the NCCN Foundation Board of Directors, as the National Comprehensive Cancer Network released its first-ever patient guidelines dedicated entirely to cancer caregivers, according to News-Medical. … Read more
Compare survival rates across detection stages When breast cancer is identified in its early, localized stages, the five-year survival rate exceeds 99%. Should the malignancy be diagnosed after spreading to the lymph nodes, the survival rate decreases to 87%, and it diminishes further to 33% if the cancer has become metastatic. Major screening guidelines recommend … Read more
Nationwide Registry Links Denosumab to Jaw Necrosis Medication-related osteonecrosis of the jaw affected 12.6% of breast cancer patients treated with denosumab for bone metastases during a registry study published on September 29, 2026, in Clinical Oral Investigations. Researchers at the University of Oulu conducted the retrospective population-based investigation. They combined data from the Finnish Institute … Read more
Trisha Lane, a York County mother of three diagnosed with stage four metastatic breast cancer in 2020, is preparing for the annual Breast Fest fundraiser at The Links at Gettysburg, WGAL reported. Lane is approaching six years since her diagnosis and has spent that time advocating for research and sharing her medical journey after initial … Read more
Automated breast ultrasound and handheld ultrasound achieved similar cancer detection rates in women with dense breasts, though the automated technology yielded a lower false-positive rate, according to a study published in the Journal of the American College of Radiology. Breast Cancer Screening Performance in Dense Tissue Dense breast tissue and lesions both register as white … Read more
Fred Hutchinson Cancer Center Researchers Identify tRNA Molecule Linked to Prostate Cancer Treatment Resistance Researchers at the Fred Hutchinson Cancer Center in Seattle have discovered that a specific transfer RNA molecule named tRNAArg(UCU)-1 influences whether prostate cancer develops resistance to medical treatment. Nature reported that the molecule appears at high levels in prostate cancer cells … Read more
Dr. Dennis Slamon, an oncologist and researcher at the UCLA Health Jonsson Comprehensive Cancer Center, has won the 2026 Albany Prize alongside Dr. Tony Hunter of the Salk Institute for Biological Studies, News-Medical reported. The award recognizes breakthroughs in cancer biology that revealed molecular mechanisms driving tumors and produced lifesaving treatments for millions. Slamon shares … Read more
Balkan cancer mortality rates remain stubbornly elevated despite incidence levels that broadly mirror Western Europe, driven by delayed detection, weak primary care, and limited access to advanced diagnostics. According to World Health Organization data, Serbia’s age-standardised incidence rate stands at 610 per 100,000, with mortality at 315 per 100,000, both exceeding European averages. Balkan Cancer … Read more
A phase Ib/II trial evaluating the angiogenesis inhibitor famitinib combined with the CDK4/6 inhibitor dalpiciclib and fulvestrant for HR+/HER2− advanced breast cancer was terminated early. Published on July 7, 2026, in the Chinese Medical Journal, the study led by Dr. Min Yan of Henan Cancer Hospital revealed that despite a promising objective response rate of … Read more